Technical Analysis for ATE - Antibe Therapeutics Inc.

Grade Last Price % Change Price Change
F 0.295 0.00% 0.000
ATE closed up 13.46 percent on Monday, April 8, 2024, on approximately normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
MACD Bullish Signal Line Cross Bullish 13.46%
Wide Bands Range Expansion 13.46%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Stochastic Reached Oversold Weakness 11.32%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance 13 days ago
Rose Above Previous Day's High 13 days ago
Rose Above 10 DMA 13 days ago
Up 1 ATR 13 days ago
Up 5% 13 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Antibe Therapeutics Inc. Description

Antibe Therapeutics Inc. is a commercial-stage pharmaceutical company. The Company is focused on pain, inflammation and regenerative medicine. The Company's segments include Antibe Therapeutics, and Citagenix, which is a marketer and distributor of regenerative medicines serving the dental and orthopedic market places. The Company's drug design methodologies involve chemically linking a base drug to its hydrogen sulfide-releasing molecule. Its lead compound, ATB-346, combines hydrogen sulfide with naproxen, which is a non-steroidal anti-inflammatory drug (NSAID). The Company's other products include ATB-352, which is indicated for the treatment of severe acute pain, and ATB-340 is a Gastrointestinal (GI)-safe derivative of aspirin. The Company also offers regenerative medical devices, which include PentOS (CGX-283), CGX-227, CGX-443 and URIST (CGX-276), all of which target bone regeneration, and are indicated for oral and maxillofacial surgery.


Sector: Healthcare
Industry: Biotechnology
Keywords: Chemistry Derivative Medicine Pharma Pharmaceutical Chemical Drug Pain Sulfide Leasing RTT Drugs Hydrogen Medical Devices Bone Hydrogen Sulfide Places Surgery Chemical Compounds Inflammation Regenerative Medicine Acute Pain Urist Analgesics

Is ATE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 1.23
52 Week Low 0.15
Average Volume 165,032
200-Day Moving Average 0.658
50-Day Moving Average 0.683
20-Day Moving Average 0.377
10-Day Moving Average 0.321
Average True Range 0.070
RSI (14) 35.90
ADX 47.61
+DI 24.597
-DI 39.096
Chandelier Exit (Long, 3 ATRs) 0.349
Chandelier Exit (Short, 3 ATRs) 0.361
Upper Bollinger Bands 0.563
Lower Bollinger Band 0.192
Percent B (%b) 0.28
BandWidth 98.408
MACD Line -0.117
MACD Signal Line -0.121
MACD Histogram 0.0047
Fundamentals Value
Market Cap 11.38 Million
Num Shares 38.6 Million
EPS -0.07
Price-to-Earnings (P/E) Ratio -3.98
Price-to-Sales 14.05
Price-to-Book 6.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.430
Resistance 3 (R3) 0.433 0.392 0.408
Resistance 2 (R2) 0.392 0.357 0.390 0.400
Resistance 1 (R1) 0.343 0.336 0.368 0.340 0.392
Pivot Point 0.302 0.302 0.314 0.300 0.302
Support 1 (S1) 0.253 0.267 0.278 0.250 0.198
Support 2 (S2) 0.212 0.246 0.210 0.190
Support 3 (S3) 0.163 0.212 0.183
Support 4 (S4) 0.160